Integra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India.
The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of dura mater in patients undergoing cranial and spinal procedures. The matrix protects against cerebro-spinal fluid leakage and is fully resorbed and replaced by native tissue, the companies said.
Get the full story at our sister site, Drug Delivery Business News.
The post Integra, Dr. Reddy’s ink deal for DuraGen in India appeared first on MassDevice.
from MassDevice http://ift.tt/2mJqnyq
Cap comentari:
Publica un comentari a l'entrada